Insufficient scRNA-seq data for expression of SCUBE3 at single-cell level.
Insufficient scRNA-seq data for expression of SCUBE3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 11994.22 | 651 / 653 | 87% | 27.52 | 527 / 605 |
prostate | 65% | 856.09 | 159 / 245 | 43% | 1.67 | 214 / 502 |
bladder | 71% | 1682.95 | 15 / 21 | 29% | 2.72 | 148 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.37 | 1 / 1 |
blood vessel | 99% | 9837.17 | 1320 / 1335 | 0% | 0 | 0 / 0 |
kidney | 67% | 866.10 | 60 / 89 | 24% | 1.33 | 213 / 901 |
esophagus | 40% | 651.16 | 572 / 1445 | 41% | 3.28 | 75 / 183 |
intestine | 53% | 919.18 | 515 / 966 | 27% | 1.91 | 142 / 527 |
adrenal gland | 68% | 827.44 | 176 / 258 | 4% | 0.20 | 10 / 230 |
lung | 14% | 128.30 | 79 / 578 | 58% | 7.10 | 668 / 1155 |
breast | 7% | 72.62 | 32 / 459 | 63% | 10.92 | 704 / 1118 |
skin | 28% | 1140.34 | 506 / 1809 | 41% | 9.28 | 194 / 472 |
stomach | 29% | 289.84 | 104 / 359 | 37% | 2.06 | 105 / 286 |
ovary | 8% | 84.90 | 15 / 180 | 46% | 5.58 | 198 / 430 |
pancreas | 0% | 3.05 | 1 / 328 | 51% | 4.42 | 90 / 178 |
uterus | 12% | 151.81 | 21 / 170 | 29% | 4.46 | 134 / 459 |
heart | 31% | 383.93 | 271 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 3.53 | 12 / 45 |
brain | 1% | 6.50 | 18 / 2642 | 21% | 1.05 | 147 / 705 |
adipose | 21% | 351.96 | 258 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 18% | 0.71 | 14 / 80 |
muscle | 2% | 22.77 | 20 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.21 | 4 / 406 |
spleen | 0% | 2.17 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0005886 | Cellular component | plasma membrane |
GO_0070700 | Molecular function | BMP receptor binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0036122 | Molecular function | BMP binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SCUBE3 |
Protein name | Signal peptide, CUB and EGF-like domain-containing protein 3 |
Synonyms | CEGF3 |
Description | FUNCTION: Is a positive regulator of the BMP signaling pathway, required for proper chondrogenesis, osteogenesis and skeletal development. It acts as a coreceptor for BMP ligands, particularly BMP2 and BMP4, facilitating their interactions with BMP type I receptors . It is required for ligand-induced recruitment of BMP receptors to lipid rafts (By similarity). Binds to TGFBR2 and activates TGFB signaling. In lung cancer cells, could serve as an endogenous autocrine and paracrine ligand of TGFBR2, which could regulate TGFBR2 signaling and hence modulate epithelial-mesenchymal transition and cancer progression. . |
Accessions | Q8IX30 ENST00000274938.8 [Q8IX30-1] |